Proposed NIH Cancer Research Cuts Spark Industry ConcernASCOThe Trump administration’s proposed budget cuts to NIH and NCI risk hindering cancer research progress, prompting strong opposition from ASCO and ACS CAN over potential impacts on patient outcomes and innovation.